NCT00064142 2013-06-05
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC